REQUEST A DEMO
Total
USD $0.00
Search more companies

Yenher Holdings Berhad (Malaysia)

Main Activities: Offices of Other Holding Companies
Full name: Yenher Holdings Berhad Profile Updated: November 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Yen her Holdings Berhad (the 'Company') was incorporated in Malaysia under the Companies Act 2016 on 9 March 2020 as a private limited liability company under the name of Yenher Holdings Sdn Bhd and is domiciled in Malaysia.
On 3 November 2020, the Company was converted to a public limited liability company. The Company was incorporated for the purpose of undertaking, among others, a restructuring and acquisition exercise that would result in the Company becoming the holding company of Yenher AgroProducts Sdn Bhd ('Yen her Agro') and Yen her Biotech Sdn Bhd ('Yenher Biotech') (both collectively referred to as the 'subsidiaries', the acquisitions of which have been completed on 28 August 2020,
The Company was incorporated on 9 March 2020 and its acquisitions of Yenher Agro and Yenher Biotech were completed on 28 August 2020.
The Company is an investment holding company and through subsidiaries, the Company are principally involved in the manufacturing and distribution of animal health and nutrition products.
Under manufacturing operations, the Company manufacture premixes, complete feed, formulated products and biotech animal feed ingredients mainly for the poultry and swine subsectors.
Under distribution segment the Company focuses on the distribution of feed additives, vitamins, minerals, veterinary pharmaceuticals, veterinary vaccines, farm equipment, livestock reproduction products and companion animal products, that cater for the poultry, swine, ruminants, aquaculture and companion animal’s subsectors.
To complement and support the sales of manufactured and distribution products, the Company also provide value-added diagnostic and material analyses services ranging from microbiological tests, chemical tests to serology tests to the customers. Also the Company provide complimentary consulting services relating to farm management, disease diagnoses and development of animal health programmes such as farm bio-security measures, vaccination programmes and animal nutrition feeding plans to our customers.

Headquarters
No. 1628, Jalan Iks Simpang Ampat 1, Taman Iks Simpang Ampat, Simpang Ampat, Seberang Perai Selatan
Perai; Penang; Postal Code: 14100

Contact Details: Purchase the Yenher Holdings Berhad report to view the information.

Website: http://www.yenheragro.com

Basic Information
Total Employees:
Purchase the Yenher Holdings Berhad report to view the information.
Outstanding Shares:
Purchase the Yenher Holdings Berhad report to view the information.
Financial Auditors:
Purchase the Yenher Holdings Berhad report to view the information.
Incorporation Date:
2020
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Secretary
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
7.5%
Purchase this report to view the information.
3.5%
Purchase this report to view the information.
3.5%
Subsidiaries
Yenher Agro-Products Sdn Bhd
100%
Yenher Biotech Sdn. Bhd.
100%
Company Performance
Financial values in the chart are available after Yenher Holdings Berhad report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-17.39%
Total operating revenue
-16.76%
Operating profit (EBIT)
6.13%
EBITDA
8.32%
Net Profit (Loss) for the Period
-7.95%
Total assets
9.17%
Total equity
8.92%
Operating Profit Margin (ROS)
2.1%
Net Profit Margin
0.75%
Return on Equity (ROE)
-0.77%
Debt to Equity Ratio
0.51%
Quick Ratio
-0.53%
Cash Ratio
-3.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?